TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35680989

Group type: EXPERIMENTAL
Intervention: Perturbation‐based Balance Training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional Intensive Balance Training
Number of subjects: 20
Study: 34682455

Group type: EXPERIMENTAL
Intervention: Multicomponent and flexibility training (MFT)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Multicomponent training (MT)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 142
Study: 33172627

Group type: EXPERIMENTAL
Intervention: Exercise program
Number of subjects: 647

Group type: COMPARATOR
Intervention: No exercise program
Number of subjects: 647
Study: 36127077

Group type: EXPERIMENTAL
Intervention: Early ICU-VR group
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Late ICU-VR group
Number of subjects: 300

Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 300
Study: 35429901

Group type: EXPERIMENTAL
Intervention: Palbociclib plus fulvestrant
Number of subjects: 601

Group type: COMPARATOR
Intervention: Capecitabine
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: Palbociclib plus endocrine therapy (ET)
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: Palbociclib plus ET
Number of subjects: 601
Study: 34264157

Group type: EXPERIMENTAL
Intervention: CT-PET-MRI
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: CT-MRI
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: CT-PET
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: PET-MRI
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Average of three bi-modality combinations (CT-PET, CT-MRI, PET-MRI)
Number of subjects: 153
Study: 32522024

Group type: EXPERIMENTAL
Intervention: Internal acupuncturists providing yoga or Tai Chi classes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Community acupuncturists
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Longitudinal opioid utilization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pain intensity levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patient-reported outcomes
Number of subjects: 0
Study: 35546527

Group type: EXPERIMENTAL
Intervention: Everolimus regimen (low dose CNI, everolimus, and prednisolone)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Standard immunosuppressive regimen (CNI, mycophenolate mofetil, and prednisolone)
Number of subjects: 54
Study: 34164123

Group type: EXPERIMENTAL
Intervention: Radio health/nutrition education
Number of subjects: 712

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 712
Study: 35119460

Group type: EXPERIMENTAL
Intervention: Combination of visual campaign and narrative vignette from the perspective of a patient with OUD
Number of subjects: 1842

Group type: EXPERIMENTAL
Intervention: Combined visual campaign and patient vignette about the value of medication treatment for OUD
Number of subjects: 1842
Study: 34520219

Group type: EXPERIMENTAL
Intervention: VRD consolidation (bortezomib, lenalidomide, and dexamethasone)
Number of subjects: 878

Group type: COMPARATOR
Intervention: No consolidation
Number of subjects: 878

Group type: EXPERIMENTAL
Intervention: VRD consolidation
Number of subjects: 878

Group type: EXPERIMENTAL
Intervention: VRD consolidation including maintenance
Number of subjects: 878

Group type: COMPARATOR
Intervention: No consolidation including maintenance
Number of subjects: 878

Group type: EXPERIMENTAL
Intervention: VRD treatment
Number of subjects: 878
Study: 32799981

Group type: EXPERIMENTAL
Intervention: Prescriptions for children under five years
Number of subjects: 4125
Study: 35197337

Group type: EXPERIMENTAL
Intervention: Dexcom G6 CGM devices with sensors and solar chargers
Number of subjects: 50

Group type: COMPARATOR
Intervention: Safe‐Accu home glucose metres and logbooks
Number of subjects: 50
Study: 33409546

Group type: EXPERIMENTAL
Intervention: Percutaneous cryoneurolysis of splanchnic nerves
Number of subjects: 5
Study: 34907041

Group type: EXPERIMENTAL
Intervention: Combination treatment of double plasma molecular adsorption system (DPMAS) and low volume plasma exchange (PE)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Comprehensive internal medical treatment (as part of the trial group)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Comprehensive internal medical treatment (control group)
Number of subjects: 200
Study: 32576157

Group type: EXPERIMENTAL
Intervention: Overall anemia prevalence
Number of subjects: 5229

Group type: EXPERIMENTAL
Intervention: Mild anemia prevalence
Number of subjects: 5229

Group type: EXPERIMENTAL
Intervention: Moderate anemia prevalence
Number of subjects: 5229

Group type: EXPERIMENTAL
Intervention: Severe anemia prevalence
Number of subjects: 5229

Group type: EXPERIMENTAL
Intervention: Increased risk of overall anemia
Number of subjects: 5229

Group type: EXPERIMENTAL
Intervention: Increased risk of mild anemia
Number of subjects: 5229

Group type: EXPERIMENTAL
Intervention: Increased risk of moderate/severe anemia
Number of subjects: 5229

Group type: EXPERIMENTAL
Intervention: Decreased risk of moderate/severe anemia
Number of subjects: 5229

Group type: EXPERIMENTAL
Intervention: Protective factor for overall, mild and moderate/severe anemia
Number of subjects: 5229
Study: 34991130

Group type: EXPERIMENTAL
Intervention: Zishen Yutai Pill
Number of subjects: 2265

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2265
Study: 34496544

Group type: EXPERIMENTAL
Intervention: Test group (n=96) including 51 OSCC patients and 45 healthy subjects
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Verification group (n=50) including 25 OSCC patients and 25 healthy individuals
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Diagnostic panel
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Pathway analysis
Number of subjects: 76
Study: 32340780

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SGLT2 inhibitors (general reference)
Number of subjects: 0
Study: 34344250

Group type: EXPERIMENTAL
Intervention: Visual training
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Manual rotation training
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Manual training without rotational movement
Number of subjects: 121
Study: 34228127

Group type: EXPERIMENTAL
Intervention: Counseling plus nicotine replacement therapy (NRT)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Brief health education (BHE)
Number of subjects: 46
Study: 32213121

Group type: COMPARATOR
Intervention: Modified Paleolithic diet (Paleo; n=6)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Medium-chain triglyceride (MCT)‐based ketogenic diet (Keto; n=5)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Usual diet (Control; n=4)
Number of subjects: 15
Study: 32857992

Group type: EXPERIMENTAL
Intervention: 1 + 1 dosing schedule of PCV13 (6w + 1 and 14w + 1 groups)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: 1 + 1 dosing schedule of PCV10 (6w + 1 and 14w + 1 groups)
Number of subjects: 600

Group type: COMPARATOR
Intervention: 2 + 1 dosing schedule of PCV13
Number of subjects: 600

Group type: COMPARATOR
Intervention: 2 + 1 dosing schedule of PCV10
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Safety assessment
Number of subjects: 600
Study: 35260448

Group type: EXPERIMENTAL
Intervention: Intensive Nutrition Therapy
Number of subjects: 240

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 240
Study: 32513192

Group type: EXPERIMENTAL
Intervention: Habit-forming interventions (e.g., having a relative ask about pill-taking, re-packaging medications, leaving medications in view, using alarms, carrying water, linking pill-taking to radio/prayer schedules)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Routine habits (eating, bathing, sleeping)
Number of subjects: 42
Study: 36129711

Group type: EXPERIMENTAL
Intervention: Real acupuncture for 8 weeks
Number of subjects: 70

Group type: COMPARATOR
Intervention: Sham acupuncture for 8 weeks
Number of subjects: 70
Study: 33663237

Group type: EXPERIMENTAL
Intervention: Sacubitril-valsartan
Number of subjects: 464

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 464
Study: 32785689

Group type: EXPERIMENTAL
Intervention: Testosterone replacement
Number of subjects: 95
Study: 33891348

Group type: EXPERIMENTAL
Intervention: Fremanezumab quarterly (675 mg)
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Fremanezumab monthly (675/225/225 mg)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Fremanezumab
Number of subjects: 219
Study: 33206751

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil combined with tacrolimus (Group A)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Mycophenolate mofetil combined with cyclophosphamide (Group B)
Number of subjects: 234
Study: 34524005

Group type: EXPERIMENTAL
Intervention: Faster aspart
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insulin aspart (IAsp)
Number of subjects: 0
Study: 33849494

Group type: EXPERIMENTAL
Intervention: 30 g of oat bran daily for 4 weeks at lunch and dinner
Number of subjects: 112

Group type: COMPARATOR
Intervention: Standard diet for gestational diabetes (control group)
Number of subjects: 112
Study: 32296094

Group type: EXPERIMENTAL
Intervention: Herpatch Serum
Number of subjects: 180

Group type: COMPARATOR
Intervention: Compeed Patches
Number of subjects: 180

Group type: COMPARATOR
Intervention: Zovirax Cream (5% acyclovir)
Number of subjects: 180
Study: 35365344

Group type: EXPERIMENTAL
Intervention: CARD (Comfort Ask Relax Distract) system
Number of subjects: 1919

Group type: COMPARATOR
Intervention: Control (usual practices)
Number of subjects: 1919
Study: 34463746

Group type: EXPERIMENTAL
Intervention: Home hazard removal intervention delivered by an occupational therapist over 2 weeks with a 6-month booster.
Number of subjects: 310

Group type: COMPARATOR
Intervention: Usual care control consisting of annual assessments and community referral.
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Home hazard removal intervention
Number of subjects: 310
Study: 33037518

Group type: EXPERIMENTAL
Intervention: Getong Tongluo Capsule (GTC) 250 mg plus EGB-matching placebo 40 mg (GTC group)
Number of subjects: 477

Group type: EXPERIMENTAL
Intervention: EGB 40 mg plus GTC-matching placebo 250 mg (EGB group)
Number of subjects: 477

Group type: COMPARATOR
Intervention: GTC-matching placebo 250 mg plus EGB-matching placebo 40 mg (Placebo group)
Number of subjects: 477

Group type: EXPERIMENTAL
Intervention: Getong Tongluo Capsule (GTC) 250 mg
Number of subjects: 477

Group type: EXPERIMENTAL
Intervention: EGB 40 mg
Number of subjects: 477
Study: 35932550

Group type: EXPERIMENTAL
Intervention: Threat conditioning (CS+ and CS-)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Supportive social interaction
Number of subjects: 81

Group type: COMPARATOR
Intervention: Unsupportive social interaction
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: One-year follow-up
Number of subjects: 81
Study: 33078961

Group type: EXPERIMENTAL
Intervention: Automated feedback system (AFS) during practice installation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group with standard printed instruction manuals
Number of subjects: 60
Study: 35629000

Group type: EXPERIMENTAL
Intervention: Anti-disgust cognitive behavioral therapy (AD-CBT)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Cognitive behavioral therapy (CBT) alone
Number of subjects: 55
Study: 32716603

Group type: EXPERIMENTAL
Intervention: Oral irrigator with 0.06% CHX solution
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Oral irrigator with water
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (oral hygiene instruction and mechanical debridement)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All groups (including control)
Number of subjects: 60
Study: 36460991

Group type: EXPERIMENTAL
Intervention: AIDS Fighter · Health Defense (game-based health education)
Number of subjects: 0
Study: 33113956

Group type: EXPERIMENTAL
Intervention: Euglena intake
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo intake
Number of subjects: 0
Study: 35180612

Group type: EXPERIMENTAL
Intervention: IRT+MBI
Number of subjects: 36

Group type: COMPARATOR
Intervention: IRT
Number of subjects: 36
Study: 36482026

Group type: COMPARATOR
Intervention: Cathodal t-DCS
Number of subjects: 21

Group type: COMPARATOR
Intervention: Anodal t-DCS
Number of subjects: 21
Study: 33431252

Group type: EXPERIMENTAL
Intervention: Point-of-care testing (POCT) implementation
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Barriers to POCT implementation
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Motivators for POCT implementation
Number of subjects: 147
Study: 33874643

Group type: EXPERIMENTAL
Intervention: Swiss ball exercise group (n=30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Stretching group (n=30)
Number of subjects: 60
Study: 32016292

Group type: EXPERIMENTAL
Intervention: Filgotinib, 200 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Filgotinib, 100 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34952989

Group type: EXPERIMENTAL
Intervention: Cardiac telerehabilitation (CTR) program for 10 months
Number of subjects: 67

Group type: COMPARATOR
Intervention: Center-based cardiac rehabilitation (CBCR) program for 8 weeks
Number of subjects: 67
Study: 32507154

Group type: EXPERIMENTAL
Intervention: Proprioception training without visual input
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 36098384

Group type: EXPERIMENTAL
Intervention: 15° left operating table tilt
Number of subjects: 100

Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 100
Study: 33863272

Group type: EXPERIMENTAL
Intervention: Quarterly fremanezumab
Number of subjects: 838

Group type: EXPERIMENTAL
Intervention: Monthly fremanezumab
Number of subjects: 838
Study: 32893384

Group type: EXPERIMENTAL
Intervention: Ginseng, Lilii Bulbus and Poria (GLP) supplementation
Number of subjects: 120
Study: 34236303

Group type: EXPERIMENTAL
Intervention: 15 mg phentermine
Number of subjects: 932

Group type: EXPERIMENTAL
Intervention: 30 mg phentermine
Number of subjects: 932

Group type: EXPERIMENTAL
Intervention: 15 mg and 30 mg phentermine
Number of subjects: 932
Study: 36394261

Group type: EXPERIMENTAL
Intervention: Mini-sternotomy AVR
Number of subjects: 270

Group type: COMPARATOR
Intervention: Conventional median sternotomy AVR
Number of subjects: 270
Study: 33743794

Group type: EXPERIMENTAL
Intervention: Anti-inflammatory diet (exemption of gluten, dairy, sugar, and ultra-processed foods) for 3 months, with a low FODMAP diet in the first month and reintroduction of fruits and vegetables over 2 months.
Number of subjects: 100

Group type: COMPARATOR
Intervention: General recommendations for healthy eating (control group).
Number of subjects: 100
Study: 34802945

Group type: EXPERIMENTAL
Intervention: High LACE index score
Number of subjects: 88

Group type: COMPARATOR
Intervention: Low-to-moderate LACE index score
Number of subjects: 88
Study: 33299099

Group type: EXPERIMENTAL
Intervention: Genetically instrumented blood sucrose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blood fructose
Number of subjects: 0
Study: 32444201

Group type: EXPERIMENTAL
Intervention: Guided acromioplasty (GA)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Freehand acromioplasty (FA)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Both GA and FA
Number of subjects: 64
Study: 33478567

Group type: EXPERIMENTAL
Intervention: Triple low-dose antihypertensive drug combination
Number of subjects: 1268

Group type: EXPERIMENTAL
Intervention: Dual drug combination
Number of subjects: 1268

Group type: COMPARATOR
Intervention: Standard of care (monotherapy followed by dual treatment)
Number of subjects: 1268

Group type: COMPARATOR
Intervention: Standard of care with optional dose titration after 4 and 8 weeks
Number of subjects: 1268

Group type: EXPERIMENTAL
Intervention: Clinical manifestations of end-organ damage
Number of subjects: 1268

Group type: EXPERIMENTAL
Intervention: Cost-effectiveness
Number of subjects: 1268
Study: 34172326

Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate (ND)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 40
Study: 34182929

Group type: EXPERIMENTAL
Intervention: Multimodal analgesia (pre-operative acetaminophen and gabapentin, intra-operative flurbiprofen and ropivacaine, post-operative acetaminophen and celecoxib)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Multimodal analgesia
Number of subjects: 140

Group type: COMPARATOR
Intervention: Conventional opioid‐based analgesia
Number of subjects: 140
Study: 35420672

Group type: EXPERIMENTAL
Intervention: Bortezomib added to decitabine therapy
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Dependence in instrumental activities of daily living
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Cognitive impairment
Number of subjects: 96
Study: 33849006

Group type: EXPERIMENTAL
Intervention: Swimming exercise (60 min swimming/day, 6 days per week, for 8 weeks)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Swimming exercise
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sedentary normotensive group (WKY)
Number of subjects: 16
Study: 32546493

Group type: EXPERIMENTAL
Intervention: Intelligent Exercise Rehabilitation Management System (IERMS) with usual care for the first 6 weeks
Number of subjects: 70

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Intelligent Exercise Rehabilitation Management System (IERMS)
Number of subjects: 70
Study: 34883269

Group type: EXPERIMENTAL
Intervention: Collaborative care
Number of subjects: 172

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 172
Study: 34540187

Group type: EXPERIMENTAL
Intervention: Enhanced CIK cells
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 20
Study: 34224192

Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 29
Study: 32679201

Group type: EXPERIMENTAL
Intervention: Nasal high-flow treatment
Number of subjects: 363
Study: 35650612

Group type: EXPERIMENTAL
Intervention: High dose of Gyejibokryeong-hwan (GBH)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Low dose of Gyejibokryeong-hwan (GBH)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo granules
Number of subjects: 126
Study: 34275552

Group type: EXPERIMENTAL
Intervention: Distributed practice protocol (1 session/day)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Mass practice protocol (6 sessions/day)
Number of subjects: 10
Study: 32217561

Group type: EXPERIMENTAL
Intervention: azithromycin 500 mg one time per day for 3 days
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: amoxicillin 1 g three times per day for 5 days
Number of subjects: 400

Group type: COMPARATOR
Intervention: standard-of-care (no immediate antibiotic)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: azithromycin and amoxicillin (combined)
Number of subjects: 400
Study: 33892154

Group type: EXPERIMENTAL
Intervention: Yoga therapy
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Eurythmy therapy
Number of subjects: 274

Group type: COMPARATOR
Intervention: Standard physiotherapy
Number of subjects: 274
Study: 34865452

Group type: EXPERIMENTAL
Intervention: rb‐bFGF gel
Number of subjects: 100

Group type: COMPARATOR
Intervention: gel matrix
Number of subjects: 100
Study: 34717154

Group type: EXPERIMENTAL
Intervention: IRX-2 regimen (low dose 300 mg/m2 cyclophosphamide on day 1, followed by 10 days of regional perilymphatic IRX-2 cytokine injections and daily oral indomethacin, zinc, and omeprazole)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Identical regimen without IRX-2 cytokines (Regimen 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Comparison between Regimen 1 and Regimen 2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 0
Study: 32240141

Group type: EXPERIMENTAL
Intervention: New technique of carotid endarterectomy (autoarterial remodeling)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Classical carotid endarterectomy
Number of subjects: 25
Study: 35927828

Group type: EXPERIMENTAL
Intervention: Acacia honey
Number of subjects: 161

Group type: COMPARATOR
Intervention: Honey-flavoured syrup placebo
Number of subjects: 161
Study: 33653284

Group type: EXPERIMENTAL
Intervention: 10-day bismuth-containing quadruple therapy (BQT)
Number of subjects: 352

Group type: COMPARATOR
Intervention: 7-day proton-pump inhibitor-clarithromycin containing standard triple therapy (STT)
Number of subjects: 352
Study: 36434615

Group type: EXPERIMENTAL
Intervention: Oral nutritional supplements (ONS) with a high-protein-high calorie mixture containing immunonutrients (Impact®) plus nutritional counseling
Number of subjects: 180

Group type: COMPARATOR
Intervention: Nutritional counseling alone
Number of subjects: 180
Study: 34521385

Group type: EXPERIMENTAL
Intervention: Nomogram prediction model
Number of subjects: 463
Study: 32636985

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression plus standard compression therapy
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control (compression therapy alone)
Number of subjects: 52
Study: 34347947

Group type: EXPERIMENTAL
Intervention: Mepolizumab 100 mg every 4 weeks
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Mepolizumab 300 mg every 4 weeks
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Mepolizumab (both doses)
Number of subjects: 203
Study: 32748494

Group type: COMPARATOR
Intervention: Low systolic blood pressure (SBP)
Number of subjects: 412

Group type: COMPARATOR
Intervention: Antihypertensive medication
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: Continuous SBP levels
Number of subjects: 412
Study: 33258784

Group type: EXPERIMENTAL
Intervention: Patient-centered asthma management communication intervention facilitated by a smartphone-based mobile app with a Spanish-language interface.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patient-centered asthma intervention from Aim 2.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting-list control group (not explicitly detailed in the abstract).
Number of subjects: 0
Study: 35100786

Group type: EXPERIMENTAL
Intervention: Leader assigned (n = 14)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control (n = 11)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Leader assigned teams (n = 14)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control teams (n = 11)
Number of subjects: 92
Study: 32877266

Group type: EXPERIMENTAL
Intervention: HTS Amblyopia I Net software (Amb I Net) using MFBF principle (2.5 hours per week)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Patching therapy (14–42 hours per week)
Number of subjects: 54